Substituted imidazo[1,2-a]pyrazines as Syk inhibitors

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9290505
SERIAL NO

14578973

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present disclosure relates to compounds that are Syk inhibitors and to their use in the treatment of various disease states, including cancer and inflammatory conditions. In particular embodiments, the structure of the compounds is given by Formula I:

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • GILEAD SCIENCES, INC.

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Blomgren, Peter A North Branford, US 72 1298
Currie, Kevin S North Branford, US 92 2543
Kropf, Jeffrey E Branford, US 62 1102
Lee, Seung H Branford, US 56 988
Lo, Jennifer R Branford, US 19 164
Mitchell, Scott A East Haven, US 74 2368
Schmitt, Aaron C Hamden, US 27 583
Swaminathan, Sundaramoorthi Burlingame, US 46 1374
Xiong, Jin-Ming Guilford, US 10 109
Xu, Jianjun Madison, US 83 1123
Zhao, Zhongdong Guilford, US 44 629

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Sep 22, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00